1. Home
  2. GKOS vs GXO Comparison

GKOS vs GXO Comparison

Compare GKOS & GXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • GXO
  • Stock Information
  • Founded
  • GKOS 1998
  • GXO 2021
  • Country
  • GKOS United States
  • GXO United States
  • Employees
  • GKOS N/A
  • GXO N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • GXO Transportation Services
  • Sector
  • GKOS Health Care
  • GXO Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • GXO Nasdaq
  • Market Cap
  • GKOS 5.8B
  • GXO 4.8B
  • IPO Year
  • GKOS 2015
  • GXO N/A
  • Fundamental
  • Price
  • GKOS $94.00
  • GXO $51.87
  • Analyst Decision
  • GKOS Strong Buy
  • GXO Buy
  • Analyst Count
  • GKOS 12
  • GXO 13
  • Target Price
  • GKOS $131.17
  • GXO $60.62
  • AVG Volume (30 Days)
  • GKOS 693.4K
  • GXO 998.6K
  • Earning Date
  • GKOS 11-03-2025
  • GXO 11-03-2025
  • Dividend Yield
  • GKOS N/A
  • GXO N/A
  • EPS Growth
  • GKOS N/A
  • GXO N/A
  • EPS
  • GKOS N/A
  • GXO 0.53
  • Revenue
  • GKOS $432,953,000.00
  • GXO $12,683,000,000.00
  • Revenue This Year
  • GKOS $28.79
  • GXO $13.66
  • Revenue Next Year
  • GKOS $25.65
  • GXO $6.14
  • P/E Ratio
  • GKOS N/A
  • GXO $96.45
  • Revenue Growth
  • GKOS 26.70
  • GXO 22.39
  • 52 Week Low
  • GKOS $77.10
  • GXO $30.46
  • 52 Week High
  • GKOS $163.71
  • GXO $63.33
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.08
  • GXO 50.68
  • Support Level
  • GKOS $89.83
  • GXO $50.34
  • Resistance Level
  • GKOS $97.00
  • GXO $53.86
  • Average True Range (ATR)
  • GKOS 2.65
  • GXO 1.20
  • MACD
  • GKOS 0.39
  • GXO -0.30
  • Stochastic Oscillator
  • GKOS 71.27
  • GXO 33.05

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About GXO GXO Logistics Inc.

GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.

Share on Social Networks: